Cargando…

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study

PURPOSE: This qualitative study explored patient perceptions of the most burdensome symptoms of major depressive disorder (MDD), the impact of symptoms on patients’ daily lives, and patient expectations and experiences regarding the timing of onset of antidepressant pharmacotherapy. PATIENTS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baune, Bernhard T, Florea, Ioana, Ebert, Bjarke, Touya, Maëlys, Ettrup, Anders, Hadi, Monica, Ren, Hongye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476086/ https://www.ncbi.nlm.nih.gov/pubmed/34588779 http://dx.doi.org/10.2147/NDT.S325954

Ejemplares similares

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
por: Vieta, Eduard, et al.
Publicado: (2019)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study
por: Rancans, Elmars, et al.
Publicado: (2020)

Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report
por: Baune, Bernhard T, et al.
Publicado: (2010)

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
por: Kangethe, Anne, et al.
Publicado: (2021)

Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
por: Touya, Maëlys, et al.
Publicado: (2022)

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
por: Saragoussi, Delphine, et al.
Publicado: (2018)

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
por: Blumenfeld, Andrew, et al.
Publicado: (2022)

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
por: Baune, Bernhard T, et al.
Publicado: (2017)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Executive Subdomains Are Differentially Associated With Psychosocial Outcomes in Major Depressive Disorder
por: Knight, Matthew J., et al.
Publicado: (2018)

Social cognition and major depressive disorder: impact on psychosocial function and therapeutic opportunities
por: Weightman, Michael, et al.
Publicado: (2021)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder
por: Knight, Matthew J., et al.
Publicado: (2018)

Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder
por: Air, Tracy, et al.
Publicado: (2015)

The Direct and Indirect Relationship Between Social Cognition and Psychosocial Dysfunction in Major Depressive Disorder
por: Knight, Matthew J., et al.
Publicado: (2019)

A Review of the Role of Social Cognition in Major Depressive Disorder
por: Weightman, Michael James, et al.
Publicado: (2014)

Psychosocial Dysfunction in Major Depressive Disorder—Rationale, Design, and Characteristics of the Cognitive and Emotional Recovery Training Program for Depression (CERT-D)
por: Knight, Matthew James, et al.
Publicado: (2017)

Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report
por: Todder, Doron, et al.
Publicado: (2007)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study
por: Schiele, M A, et al.
Publicado: (2020)

Suicide Rates and Antidepressant Prescribing: A Casual or Causal Relationship?
por: Baune, Bernhard, et al.
Publicado: (2006)

Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
por: Chokka, Pratap, et al.
Publicado: (2021)

Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
por: Baune, Bernhard T., et al.
Publicado: (2019)

Role of 5-HT(3) Receptors in the Antidepressant Response
por: Bétry, Cécile, et al.
Publicado: (2011)

Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
por: Haro, Josep Maria, et al.
Publicado: (2019)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study
por: Ebert, Bjarke, et al.
Publicado: (2017)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Clinical, Functional, and Biological Correlates of Cognitive Dimensions in Major Depressive Disorder – Rationale, Design, and Characteristics of the Cognitive Function and Mood Study (CoFaM-Study)
por: Baune, Bernhard T., et al.
Publicado: (2016)

Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
por: Greene, Mallik, et al.
Publicado: (2018)

Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m1jekfscn3is8p9he3snq4ofsd